Clinical characteristics of patients with constrictive pericarditis after coronary bypass surgery

K Matsuyama1, M Matsumoto, T Sugita

  • 1Department of Cardiovascular Surgery, Tenri Hospital, Nara, Japan.

Insights

Constrictive pericarditis (CP) after coronary artery bypass grafting (CABG) affects 2.4% of patients. Early pericardial effusion drainage is crucial for preventing CP, especially in warfarin-treated patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pericardial Diseases

Background:

  • Constrictive pericarditis (CP) is a rare but serious complication following cardiac surgery.
  • Coronary artery bypass grafting (CABG) is a common cardiac procedure where CP can occur postoperatively.

Purpose of the Study:

  • To evaluate the clinical characteristics of patients who develop constrictive pericarditis (CP) after coronary artery bypass grafting (CABG).
  • To identify risk factors associated with the development of CP post-CABG.
  • To determine the importance of managing postoperative pericardial effusion.

Main Methods:

  • Retrospective analysis of 463 patients who underwent isolated CABG between January 1989 and March 1999.
  • Clinical data collection and diagnosis of CP via cardiac catheterization.
  • Univariate and multivariate statistical analysis to identify risk factors.

Main Results:

  • Eleven patients (2.4%) developed CP after CABG, with a median onset of 4 weeks post-surgery.
  • Significant risk factors for CP included normal left ventricular ejection fraction, warfarin use, and early postoperative pericardial effusion.
  • Failure to drain significant postoperative pericardial effusion was identified as a risk factor for CP development.

Conclusions:

  • Early pericardial effusion drainage in patients undergoing CABG is important for preventing subsequent constrictive pericarditis.
  • Particular attention should be given to patients on warfarin or with normal left ventricular function.
  • Management of postoperative pericardial effusion may mitigate the risk of developing CP.

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...